The prospective, multi-center phase 3 PRIMARY randomized trial tested the additive diagnostic value of PSMA PET imaging in high-risk men with negative or equivocal MRI in the diagnosis of significant ...

A short course of darolutamide (Nubeqa) enhanced the imaging signal of prostate-specific membrane antigen (PSMA)-PET in a ...

An imaging test could safely halve the number of people who need a biopsy for suspected prostate cancer following inconclusive or reassuring results from an MRI scan, new research has found. Findings ...

Douglas M. Dahl, MD, Chief of the Division of Urologic Oncology at Massachusetts General Hospital and Associate Professor of Surgery at Harvard Medical School in Boston, Massachusetts, said PSMA PET ...

Socio-economic disparities in prostate cancer hospitalizations and outcomes across the United States. Informed decision-making about germline testing among Veterans with advanced prostate cancer (APC) ...

An overview of metastatic castration-resistant prostate cancer (mCRPC) and the role of PSMA in mCRPC. Alicia Morgans, MD: Welcome to the CURE Connections® program on radiopharmaceutical PSMA [prostate ...

The trial design for ARASTEP is highlighted in the following schema: Two special considerations for ARASTEP are that all patients have maximally treated pelvic disease and that metastasis directed ...

Examples include (i) “low” PSMA uptake in a slightly enlarged lymph node (s) in men with newly diagnosed or recurrent ...

Prostate-specific membrane antigen (PSMA) is a protein found in small amounts in your prostate gland. When you have prostate cancer, you have many times more PSMA than normal. This makes PSMA a good ...

Positron Emission Tomography (PET) is a nuclear medicine procedure used to examine various body tissue functions to identify certain conditions. Biochemical changes in an organ or tissue can be traced ...